|
41 |
Handbook of Therapeutic Antibodies
Weinheim : Wiley-VCH, 2014, 2., Auflage
|
|
|
|
42 |
Handbook of Therapeutic Antibodies
Weinheim : Wiley-VCH, 2014, 2., Auflage
|
|
|
43 |
Cell‐free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments
Enthalten in Engineering in life sciences Bd. 14, 2014, Nr. 4: 387-398. 12 S.
|
|
|
|
44 |
Identification of a new epitope for HIV‐neutralizing antibodies in the gp41 membrane proximal external region by an Env‐tailored phage display library
Enthalten in European journal of immunology Bd. 43, 2013, Nr. 2: 499-509. 11 S.
|
|
|
|
45 |
Antibody production in Bacillus megaterium: Strategies and physiological implications of scaling from microtiter plates to industrial bioreactors
Enthalten in Biotechnology journal Bd. 6, 2011, Nr. 12: 1516-1531. 16 S.
|
|
|
|
46 |
Single chain Fab (scFab) fragment
Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2007
|
|
|
|
47 |
Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use
Enthalten in Nature methods Bd. 17, 27.7.2020, Nr. 8, date:8.2020: 755-756
|
|
|
|
48 |
Animal-free alternatives and the antibody iceberg
Enthalten in Nature biotechnology Bd. 38, 12.10.2020, Nr. 11, date:11.2020: 1234-1239
|
|
|
|
49 |
Baculovirus-free insect cell expression system for high yield antibody and antigen production
Enthalten in Scientific reports Bd. 10, 7.12.2020, Nr. 1, date:12.2020: 1-10
|
|
|
|
50 |
COR-101, ein menschlicher Antikörper gegen COVID-19
Enthalten in Biospektrum Bd. 27, 12.2.2021, Nr. 1, date:2.2021: 46-48
|
|
Administration
